BD Focus and Areas of Interest

 

			Late stage recombinants to support growth in core areas
			Other recombinants either adjacencies or complementary to our pipeline or commercial call point
			Geographic expansion: license products for European expansion and emerging markets
			Co-promotion opportunities to support commercial
			Opportunity to leverage our commercial infrastructure
			Partnering for clinical development and indication expansion
			Identify delivery technologies for plasma products
			Proven track record on partnership and external alliance